Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Farmers Insurance
Federal Trade Commission
Teva
UBS
Merck
Baxter
Johnson and Johnson

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LYSTEDA

« Back to Dashboard

Clinical Trials for Lysteda

Trial ID Title Status Sponsor Phase Summary
NCT00113568 Safety Study of XP12B in Women With Menorrhagia Completed Ferring Pharmaceuticals Phase 3 The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia.
NCT00386308 Efficacy and Safety Study of XP12B in Women With Menorrhagia Completed Ferring Pharmaceuticals Phase 3 The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
NCT00401193 Efficacy and Safety of XP12B in Women With Menorrhagia Completed Ferring Pharmaceuticals Phase 3 The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Lysteda

Condition Name

Condition Name for Lysteda
Intervention Trials
Heavy Menstrual Bleeding 5
Menorrhagia 5
Blood Loss, Surgical 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lysteda
Intervention Trials
Hemorrhage 9
Menorrhagia 8
Blood Loss, Surgical 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lysteda

Trials by Country

Trials by Country for Lysteda
Location Trials
United States 95
Brazil 1
United Kingdom 1
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lysteda
Location Trials
California 4
Ohio 4
Texas 3
Louisiana 3
Michigan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lysteda

Clinical Trial Phase

Clinical Trial Phase for Lysteda
Clinical Trial Phase Trials
Phase 4 4
Phase 3 6
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lysteda
Clinical Trial Phase Trials
Completed 5
Recruiting 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lysteda

Sponsor Name

Sponsor Name for Lysteda
Sponsor Trials
Ferring Pharmaceuticals 4
Kay I Waud MD PhD 1
University of Pittsburgh 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lysteda
Sponsor Trials
Other 13
Industry 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Federal Trade Commission
Accenture
Cipla
Fish and Richardson
Argus Health
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.